HomeCompareQYLD vs PODD

QYLD vs PODD: Dividend Comparison 2026

QYLD yields 12.24% · PODD yields 0.96%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QYLD wins by $5.5K in total portfolio value· pulled ahead in Year 8
10 years
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
12.24%
Share price
$16.70
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$6,038.84
Full QYLD calculator →
PODD
PODD
● Live price
0.96%
Share price
$208.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$102.34
Full PODD calculator →

Portfolio growth — QYLD vs PODD

📍 QYLD pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQYLDPODD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QYLD + PODD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QYLD pays
PODD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QYLD
Annual income on $10K today (after 15% tax)
$1,040.82/yr
After 10yr DRIP, annual income (after tax)
$5,133.01/yr
PODD
Annual income on $10K today (after 15% tax)
$81.73/yr
After 10yr DRIP, annual income (after tax)
$86.99/yr
At 15% tax rate, QYLD beats the other by $5,046.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QYLD + PODD for your $10,000?

QYLD: 50%PODD: 50%
100% PODD50/50100% QYLD
Portfolio after 10yr
$23.8K
Annual income
$3,070.59/yr
Blended yield
12.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PODD right now

QYLD
No analyst data
PODD
Analyst Ratings
36
Buy
10
Hold
3
Sell
Consensus: Buy
Price Target
$357.25
+71.7% upside vs current
Range: $286.00 — $435.00
Altman Z
7.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QYLD buys
1
PODD buys
0
PoliticianChamberTickerTypeAmountDate
Tim Moore🏢 House$QYLD▼ Sell$15,001 - $50,0002025-05-02
Tim Moore🏢 House$QYLD▲ Buy$15,001 - $50,0002025-04-07
Dwight Evans🏢 House$QYLD▼ Sell$1,001 - $15,0002022-11-14
Dwight Evans🏢 House$QYLD▼ Sell$1,001 - $15,0002020-10-29
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQYLDPODD
Forward yield12.24%0.96%
Annual dividend / share$2.04$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$26.5K$21.0K
Annual income after 10y$6,038.84$102.34
Total dividends collected$28.5K$995.00
Payment frequencymonthlyquarterly
SectorETFStock

Year-by-year: QYLD vs PODD ($10,000, DRIP)

YearQYLD PortfolioQYLD Income/yrPODD PortfolioPODD Income/yrGap
1$10,384$1,224.49$10,796$96.15$412.00PODD
2$10,900$1,388.18$11,649$97.01$749.00PODD
3$11,576$1,590.76$12,562$97.83$986.00PODD
4$12,447$1,844.20$13,540$98.60$1.1KPODD
5$13,567$2,164.97$14,587$99.32$1.0KPODD
6$15,003$2,576.05$15,708$100.00$705.00PODD
7$16,853$3,110.04$16,909$100.64$56.00PODD
8← crossover$19,251$3,813.85$18,193$101.24+$1.1KQYLD
9$22,390$4,756.08$19,569$101.81+$2.8KQYLD
10$26,548$6,038.84$21,041$102.34+$5.5KQYLD

QYLD vs PODD: Complete Analysis 2026

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

PODDStock

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Full PODD Calculator →
📬

Get this QYLD vs PODD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QYLD vs XYLDQYLD vs JEPIQYLD vs JEPQQYLD vs RYLDQYLD vs QYLGQYLD vs SCHDQYLD vs OQYLD vs KO

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.